NorthWest Biotherapeutics Inc (NWBO)

[Umibe5690]

Hi ADVFN_doclee:

You are correct that an R/S, by itself, does not change the market cap. There are fewer shares O/S but the price rises proportionately so that the MC is the same as it was pre-R/S.

However, in the case of NWBO, do we have any precedent as to what would happen(more precisely what did happen) in connection with an R/S? Indeed we do. Post R/S, the share price was devastated by short manipulation and, of course, by devastating dilution engendered by vulture financing. Post R/S, the share price cratered to $0.14. So we know that after the R/S, the MC was not safeguarded in the least, but was literally slaughtered.

In NWBO's case, I submit that not only is an R/S unnecessary, but NWBO's history tells us that an R/S set the stage for manipulation at a higher altitude and management's destruction of shareholder value through highly toxic vulture financing. Repeated financings at high discounts to market plus warrants just devastated the MC. I don't know about you, but burned once by an NWBO R/S is more than enough.

If management decides to go the R/S route once again..." because we need to uplist to Nasdaq, etc. in order to attract institutions and anyway things are different now, blah, blah, blah...", shareholders would be extremely naive to go along with this.

An R/S would give MMs much desired altitude to short away and management to once again engage in repeated toxic financings. Management will forget history and repeat it again. No thank you. Rather, get the share price up by achieving the important endpoints. Forget about artificial props. If NWBO hits the data home run, it is a new ball game. Everyone will want to get in. Period. JMHO and two cents.